Business Context and Reporting Period
Company: Axil Brands, Inc. (AXIL)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended February 28, 2025
Business Overview: Axil Brands manufactures, markets, and distributes high-tech hearing enhancement/protection products and professional hair/skin care products. The company operates two reportable segments: Hearing Enhancement and Protection, and Hair Care and Skin Care. The company recently uplisted to the NYSE American and is exploring potential divestiture of its hair and skin care business.
Key Financial Metrics
| Metric | Three Months Ended Feb 28, 2025 | Nine Months Ended Feb 28, 2025 |
|---|---|---|
| Net Sales | $6,922,367 | $20,506,213 |
| Gross Profit | $4,966,428 (71.7% margin) | $14,618,123 (71.3% margin) |
| Operating Income | $583,109 | $1,115,278 |
| Net Income | $576,662 | $1,100,563 |
| Diluted EPS | $0.07 | $0.13 |
| Cash and Equivalents (End of Period) | $4,743,470 | |
| Operating Cash Flow (9 Months) | $1,734,230 | |
| Total Debt (Notes Payable) | $140,958 (EIDL Loan) |
Material Changes vs. Prior Period
- Revenue: Net sales increased 7.0% quarter-over-quarter (QoQ) to $6.92M, driven by direct-to-consumer sales and distributor expansion. However, sales decreased 2.3% year-over-year (YoY) for the nine-month period to $20.5M, attributed to reduced advertising spend in the first two quarters.
- Profitability: Operating income improved significantly QoQ, turning a $103,879 loss in the prior year quarter into a $583,109 profit. Nine-month operating income decreased 16.4% to $1.12M, primarily due to a $699,203 increase in non-cash stock-based compensation.
- Expenses: Operating expenses decreased 7.3% QoQ due to lower advertising costs. Nine-month expenses decreased 4.9%, aided by a $218,699 forgiveness of a related-party account payable, which was partially offset by higher consulting fees for market expansion.
- Cash Flow: Operating cash flow surged to $1.73M for the nine months ended Feb 28, 2025, compared to $339,323 in the prior year, largely due to inventory liquidation and the aforementioned payable forgiveness.
Guidance, Outlook, and Risks
- Strategic Initiatives: Management is accelerating a supply chain transition to mitigate U.S. trade policy risks and tariffs, including relocating senior manufacturing leadership to the U.S. and establishing domestic production capabilities.
- Divestiture: The company is exploring options for its hair care and skin care business, which may result in a divestiture. No timeline or assurance of completion is provided.
- Liquidity: Management believes current cash balances and operating cash flows are sufficient to meet working capital requirements for at least one year. No immediate plans for additional financing exist, though future capital needs may arise.
- Risks: Key risks include exposure to tariffs and trade restrictions, reliance on overseas manufacturing (two vendors accounted for ~91% of purchases), potential inability to realize benefits from new market expansions, and the uncertainty of the potential divestiture of the hair/skin care segment.
Investor Verification Checklist
- Stock-Based Compensation Impact: Verify the sustainability of profitability given the $860,517 in stock-based compensation expense for the nine-month period, which significantly impacted net income.
- Supplier Concentration: Assess the risk associated with the two largest manufacturing vendors accounting for 65.1% and 26.5% of purchases, respectively, and the timeline for domestic manufacturing transition.
- Divestiture Progress: Monitor updates regarding the potential sale of the hair and skin care business and its impact on future revenue streams.
- Inventory Levels: Review inventory turnover and obsolescence reserves, noting the $23,448 reserve for slow-moving inventory as of Feb 28, 2025.
- Related Party Transactions: Confirm the terms and ongoing nature of consulting fees paid to entities controlled by the CEO and CFO/COO ($278,000 total for the nine months).